Prevention of intravascular catheter-related infections

被引:688
作者
Mermel, LA
机构
[1] Rhode Isl Hosp, Div Infect Dis, Providence, RI 02903 USA
[2] Brown Univ, Sch Med, Providence, RI 02912 USA
关键词
D O I
10.7326/0003-4819-132-5-200003070-00009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To review the literature on prevention of intravascular catheter-related infections. Data Sources: The MEDLINE database, conference proceedings, and bibliographies of review articles and book chapters were searched for relevant articles. Primary authors were contacted directly if data were incomplete. Study Selection: Studies met the following criteria unless otherwise stated: Trials were prospective and randomized; catheters were inserted into new sites, not into old sites over guidewires; catheter cultures were done by using semi-quantitative or quantitative methods; and, for prospective studies, catheter-related bloodstream infection was confirmed by microbial growth from percutaneously drawn blood cultures that matched catheter cultures. Data Extraction: Data on population, methods, preventive strategy, and outcome (measured as catheter-related bloodstream infections) were gathered. The quality of the data was graded by using preestablished criteria. Data Synthesis: The recommended preventive strategies with the strongest supportive evidence are full barrier precautions during central venous catheter insertion; subcutaneous tunneling short-term catheters inserted in the internal jugular or femoral veins when catheters are not used for drawing blood; contamination shields for pulmonary artery catheters; povidone-iodine ointment applied to insertion sites of hemodialysis catheters; specialized nursing teams caring for patients with short-term peripheral venous catheters, especially at institutions with a high incidence of catheter-related infection; no routine replacement of central venous catheters; antiseptic chamber-filled hub or hub-protective antiseptic sponge for central venous catheters; and use of chlorhexidine-silver sulfadiazine-im impregnated or minocycline-rifampin-impregnated short-term central venous catheters if the rate of infection is high despite adherence to other strategies that do not incorporate antimicrobial agents (for example, maximal barrier precautions). Conclusions: Simple interventions can reduce the risk for serious catheter-related infection. Adequately powered randomized trials are needed.
引用
收藏
页码:391 / 402
页数:12
相关论文
共 133 条
[1]  
[Anonymous], 1998, HOSP INFECT
[2]   Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: Results from a prospective, randomized trial [J].
Appelgren, P ;
RansjO, U ;
Bindslev, L ;
Espersen, F ;
Larm, O .
CRITICAL CARE MEDICINE, 1996, 24 (09) :1482-1489
[3]   Microbiologic evaluation of needleless and needle-access devices [J].
Arduino, MJ ;
Bland, LA ;
Danzig, LE ;
McAllister, SK ;
Aguero, SM .
AMERICAN JOURNAL OF INFECTION CONTROL, 1997, 25 (05) :377-380
[4]   Heparin-induced thrombocytopenia and thrombosis [J].
Arepally, G ;
Cines, DB .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 1998, 16 (03) :237-247
[5]  
ARMSTRONG P, 1998, J HOSP INFECT SA, V40
[6]   CONSEQUENCES OF INTRAVASCULAR CATHETER SEPSIS [J].
ARNOW, PM ;
QUIMOSING, EM ;
BEACH, M .
CLINICAL INFECTIOUS DISEASES, 1993, 16 (06) :778-784
[7]   Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters [J].
Bach, A ;
Schmidt, H ;
Bottiger, B ;
Schreiber, B ;
Bohrer, H ;
Motsch, J ;
Martin, E ;
Sonntag, HG .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (02) :315-322
[8]   VERY LOW-DOSES OF WARFARIN CAN PREVENT THROMBOSIS IN CENTRAL VENOUS CATHETERS - A RANDOMIZED PROSPECTIVE TRIAL [J].
BERN, MM ;
LOKICH, JJ ;
WALLACH, SR ;
BOTHE, A ;
BENOTTI, PN ;
ARKIN, CF ;
GRECO, FA ;
HUBERMAN, M ;
MOORE, C .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (06) :423-428
[9]  
BOIDIN R, 1999, 9 ANN SCI M SOC HEAL, P50
[10]  
BONAWITZ SC, 1991, AM SURGEON, V57, P618